Eurazeo Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Eurazeo ha aumentado sus beneficios a una tasa media anual de 50.8%, mientras que los beneficios de la industria de Diversified Financial han experimentado un crecimiento de 19.9% anual. Los ingresos han ido disminuyendo a una tasa media de 6.5% al año. La rentabilidad financiera de Eurazeo es de 22.2%, y sus márgenes netos son de 450.5%.

Información clave

50.8%

Tasa de crecimiento de los beneficios

51.3%

Tasa de crecimiento del BPA

Crecimiento de la industria Diversified Financial	26.8%
Tasa de crecimiento de los ingresos	-6.5%
Rentabilidad financiera	22.2%
Margen neto	450.5%
Próxima actualización de resultados	25 Jul 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Eurazeo. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ENXTPA:RF Ingresos, gastos y beneficios (EUR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	405	1,824	182
30 Sep 23	1,994	2,156	464
30 Jun 23	3,583	2,488	1,841
31 Mar 23	4,615	1,542	2,091
31 Dec 22	5,646	595	1,245
30 Sep 22	5,894	801	1,489
30 Jun 22	6,142	1,007	1,734
31 Mar 22	6,450	1,294	1,952
31 Dec 21	6,759	1,580	2,170
30 Sep 21	6,051	1,142	2,070
30 Jun 21	5,343	703	1,971
31 Mar 21	4,881	271	1,912
31 Dec 20	4,419	-161	1,853
30 Sep 20	4,385	-303	1,899
30 Jun 20	4,352	-444	1,946
31 Mar 20	4,748	-165	1,980
31 Dec 19	5,143	114	2,014
30 Sep 19	5,125	193	1,976
30 Jun 19	5,106	271	1,939
31 Mar 19	5,013	280	1,899
31 Dec 18	4,920	289	1,859
30 Sep 18	4,795	394	1,785
30 Jun 18	4,671	499	1,712
31 Mar 18	4,344	490	1,605
31 Dec 17	4,017	481	1,498
30 Sep 17	4,026	552	1,421
30 Jun 17	4,036	624	1,344
31 Mar 17	3,522	575	1,161
31 Dec 16	3,009	525	978
30 Sep 16	3,097	302	1,299
30 Jun 16	1,389	79	583
31 Mar 16	2,588	678	811
31 Dec 15	3,788	1,277	1,038
30 Sep 15	3,721	1,276	944
30 Jun 15	5,452	1,276	1,888
31 Mar 15	4,785	593	2,001
31 Dec 14	4,118	-89	2,114
30 Sep 14	4,255	25	2,077
30 Jun 14	4,392	139	2,041
31 Mar 14	4,817	350	2,060
31 Dec 13	5,243	561	2,080
30 Sep 13	5,146	409	2,076
30 Jun 13	5,049	257	2,073

Ingresos de calidad: RF tiene un gran one-off gain de €1.8B impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.

Margen de beneficios creciente: Los actuales márgenes de beneficio de RF son superiores a los del año pasado (10.5%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lRF han crecido significativamente en un 50.8% al año.

Acelerando crecimiento: El crecimiento de los beneficios de RF en el último año (206.5%) supera su media de 5 años (50.8% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de RF en el último año (206.5%) superó al de la industria Diversified Financial -30.8%.

Eurazeo Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

First half 2023 earnings released: EPS: €25.36 (vs €1.33 loss in 1H 2022)

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

First half 2022 earnings released

Recent updates

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

If EPS Growth Is Important To You, Eurazeo (EPA:RF) Presents An Opportunity

There Is A Reason Eurazeo SE's (EPA:RF) Price Is Undemanding

Eurazeo SE, Annual General Meeting, May 07, 2024

Does Eurazeo (EPA:RF) Deserve A Spot On Your Watchlist?

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

First half 2023 earnings released: EPS: €25.36 (vs €1.33 loss in 1H 2022)

Should You Be Adding Eurazeo (EPA:RF) To Your Watchlist Today?

New major risk - Revenue and earnings growth

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Upcoming dividend of €2.20 per share at 3.3% yield

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

We Ran A Stock Scan For Earnings Growth And Eurazeo (EPA:RF) Passed With Ease

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

Consensus forecasts updated

Consensus forecasts updated

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Price target decreased to €89.79

Here's Why We Think Eurazeo (EPA:RF) Is Well Worth Watching

First half 2022 earnings released

Consensus forecasts updated

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Consensus forecasts updated

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Price target increased to €80.63

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Should Eurazeo SE (EPA:RF) Be Part Of Your Income Portfolio?

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Price target increased to €69.86

Eurazeo SE Announces Its Intention to Resume Distribution

Price target raised to €68.75

Eurazeo SE to Report Fiscal Year 2020 Results on Mar 11, 2021

New 90-day high: €63.35

IK Investment Partners and Luxempart S.A. (BDL:LXMPR) agreed to acquire 20% stake in iM Global Partner from Eurazeo SE (ENXTPA:RF) for €70 million.

Investors Who Bought Eurazeo (EPA:RF) Shares Five Years Ago Are Now Up 48%

AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.

New 90-day high: €59.85

New 90-day high: €57.35

Eurazeo Capital managed by Eurazeo SE (ENXTPA:RF), IK Investment Partners Fund IX managed by IK Investment Partners and the management team completed the acquisition of an unknown majority stake in QUESTEL SAS from IK VIII, a fund of IK Investment Partners and Raise Investissement, SAS.

What Can We Make Of Eurazeo's (EPA:RF) CEO Compensation?

New 90-day high: €56.20

Desglose de ingresos y gastos
Beta